IMARC Group’s report titled “Veterinary Vaccines Market Report by Vaccine Type (Livestock Vaccines, Companion Animal Vaccines), Technology (Attenuated Live Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, and Others), Route of Administration (Subcutaneous, Intramuscular, Intranasal), Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies and Drug Stores, and Others), and Region 2025-2033”. The global veterinary vaccines market size reached USD 14.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 29.6 Billion by 2033, exhibiting a growth rate (CAGR) of 7.71% during 2025-2033.

Factors Affecting the Growth of Veterinary Vaccines Industry:

  • Increasing Pet Ownership and Companion Animal Population:

More people are buying vaccines for their pets. This trend is driven by the increasing pet population worldwide. When people adopt pets, they want to ensure their health and prevent illness. In North America and Europe, pets are becoming more popular. Many households in these regions now have pets to care for. As China and India grow wealthier, pet owners there are also spending more on their animals' health. With more disposable income, vaccine sales are rising. The demand for vaccines increases as more families adopt pets. A larger pet population also raises the risk of spreading diseases. Vaccines protect pets from serious illnesses like rabies, canine distemper, feline leukemia, and parvovirus. They are essential for maintaining pet health. Today, many pet owners understand the importance of vaccines. This awareness leads to more pet owners choosing to vaccinate their animals.

  • Significant Technological Advancements and Product Innovations:

Man-made and customized products drive veterinary vaccine development. Over the past ten years, veterinary health care has advanced significantly. Biotechnology, genomics, and immunology are key to this rapid growth. New technologies have transformed vaccine production and improvement. Today's vaccines are more effective, thanks to scientific changes to their DNA. A major breakthrough is the use of recombinant DNA to create vaccines. Scientists insert genetic material from pathogens into host cells. This process helps the body develop targeted responses to viruses. Recombinant DNA vaccines outperform traditional methods. They offer safer results, stronger immune responses, and longer-lasting protection.

  • Increasing Incidence of Zoonotic Diseases:

Zoonotic diseases drive the growth of the veterinary vaccines market. These diseases, which can spread from animals to humans, pose serious public health risks. Urbanization and changes in land use increase infection rates. This happens as humans and animals live closer together. Rabies serves as a key example. This fatal viral infection affects both species and is mainly spread through bites from infected animals, like dogs, bats, or wildlife. Vaccination is crucial for rabies prevention. Large-scale campaigns targeting both domestic and wild animals help control its spread. In regions where rabies is common, the demand for vaccines is high, further boosting market growth.

Grab a sample PDF of this report: https://www.imarcgroup.com/veterinary-vaccines-market/requestsample

Leading Companies Operating in the Global Veterinary Vaccines Industry:

  • Boehringer Ingelheim International GmbH
  • Ceva Santé Animale
  • Elanco Animal Health Incorporated
  • Hester Biosciences Limited
  • HIPRA, Indian Immunologicals Limited
  • Merck & Co. Inc.
  • Neogen Corporation
  • Phibro Animal Health Corporation
  • Virbac SA and Zoetis Inc.

Veterinary Vaccines Market Report Segmentation:

By Vaccine Type:

  • Livestock Vaccines
  • Bovine Vaccines
  • Poultry Vaccines
  • Porcine Vaccines
  • Others
  • Companion Animal Vaccines
  • Canine Vaccines
  • Feline Vaccines
  • Equine Vaccines

Livestock vaccines hold maximum number of shares due to the extensive global demand for vaccines to prevent infectious diseases in livestock populations, which are vital for ensuring food security and sustaining agricultural productivity.

By Technology:

  • Attenuated Live Vaccines
  • Inactivated Vaccines
  • Toxoid Vaccines
  • Recombinant Vaccines
  • Others

Attenuated live vaccines dominate the market due to their ability to closely mimic natural infections, eliciting robust and long-lasting immune responses against a broad spectrum of pathogens in both veterinary and human medicine.

By Route of Administration:

  • Subcutaneous
  • Intramuscular
  • Intranasal

Subcutaneous represents the largest segment due to its ease of administration, high patient acceptance, and ability to provide sustained release of vaccine antigens.

By Distribution Channel:

  • Veterinary Hospitals
  • Veterinary Clinics
  • Pharmacies and Drug Stores
  • Others

Veterinary clinics dominate the market due to their role as primary points of contact for pet owners seeking comprehensive veterinary care, including vaccination services, for their animals.

Regional Insights:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

North America’s dominance in the veterinary vaccines market is attributed to factors such as high pet ownership rates, stringent regulatory standards, advanced healthcare infrastructure, and robust research and development activities in the veterinary vaccines sector.

Global Veterinary Vaccines Market Trends:

Government initiatives and policies aimed at promoting animal health and welfare play a key role in driving the veterinary vaccines market. Many governments around the world implement vaccination programs by targeting livestock populations to control and prevent the spread of infectious diseases, enhance food security, and support agricultural productivity. These programs often include subsidies or incentives to encourage farmers and livestock producers to vaccinate their animals regularly, thereby increasing the demand for veterinary vaccines. Additionally, stringent regulations mandating the vaccination of certain animals such as pets, working animals, and livestock further drive market growth by ensuring compliance with preventive healthcare measures. Government-funded research grants and collaborations with pharmaceutical companies also promote innovation in vaccine development, leading to the introduction of new and improved veterinary vaccines to address emerging disease threats and public health concerns.

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact US

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1–631–791–1145